Table 2.

Non-HLA SNPs that reached a statistical significance of p < 5 × 10⁻⁵.

CHR	SNP	A1	MAF in cases	MAF in controls	P	OR (95% CI)	Gene	Region
1	rs1325190	A	0.08	0.17	2.30E-06	0.42	LOC100131866 | NR5A2	Intergenic
2	rs12470623	A	0.34	0.46	2.51E–05	0.61(0.48–0.77)	LOC100131131 | IL1R1	Intergenic
2	rs6752379	A	0.34	0.46	2.51E–05	0.61(0.48–0.77)	LOC100131131 | IL1R1	Intergenic
2	rs13001315	A	0.38	0.50	4.14E–05	0.62 (0.50–0.78)	LOC100131131 | IL1R1	Intergenic
2	rs11123911	A	0.38	0.49	4.61E–05	0.62 (0.50–0.78)	LOC100131131 | IL1R1	Intergenic
2	rs6761201	G	0.08	0.16	3.45E–05	0.47 (0.33–0.68)	ICOS	Intron
4	rs36110812	G	0.48	0.37	4.25E–05	1.60 (1.28–2.01)	LOC389203 | RBPJ	Intergenic
5	rs2405528	A	0.17	0.27	2.16E–05	0.55 (0.41–0.72)	IRF1	Intron
5	rs886286	G	0.17	0.27	1.72E–05	0.54 (0.41–0.72)	IRF1	Intron
5	rs757105	A	0.17	0.27	1.93E–05	0.55 (0.41–0.72)	IRF1	Intron
5	rs2522047	A	0.16	0.27	1.26E–05	0.53 (0.40–0.71)	IRF1	Intron
5	rs2706393	A	0.17	0.27	1.93E–05	0.55 (0.41–0.72)	IRF1	Intron
5	rs2522050	A	0.17	0.27	2.71E–05	0.55 (0.42–0.73)	IRF1	UTR
5	rs2706395	T	0.17	0.27	1.93E–05	0.55 (0.40–0.72)	IRF1	UTR
5	rs2522056	A	0.15	0.24	3.42E–05	0.54 (0.40–0.72)	IRF1	UTR
6	rs173286	G	0.47	0.36	3.27E–05	1.62 (1.29–2.03)	KIAA1919 | REV3L	Intergenic
6	rs25638	I	0.47	0.36	3.27E–05	1.62 (1.29–2.03)	KIAA1919 | REV3L	Intergenic
6	rs240959	A	0.44	0.33	2.73E–05	1.64 (1.30–2.06)	KIAA1919 | REV3L	Intergenic
6	rs71562296	A	0.12	0.20	4.36E–05	0.51 (0.37–0.71)	LOC643749 | TRAF3IP2	Intergenic
11	rs12421158	A	0.47	0.34	3.94E–06	1.72 (1.36–2.16)	KIAA1542	Intron
17	rs7218037	G	0.46	0.34	1.45E–05	1.66	NXN | LOC100130876	Intergenic
17	rs9904554	A	0.37	0.27	4.78E–05	1.64	ALOX15B	Coding